ArticleAmygdala activity contributes to the dissociative effect of cannabis on pain perceptionLee, Michael C.a,d,*; Ploner, Markusa,b; Wiech, Katjaa; Bingel, Ulrikea,c; Wanigasekera, Vishvarania; Brooks, Jonathana; Menon, David K.d; Tracey, Irenea Author Information Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article. aCentre for Functional MRI of the Brain (FMRIB), Department of Clinical Neurology and Nuffield Department of Clinical Neurosciences, Division of Anaesthesia, University of Oxford, Oxford, UK bDepartment of Neurology, Technische Universtität München, Munich, Germany cNeuroImage Nord, Department of Neurology, University Medical Center, Hamburg-Eppendorf, Germany dDepartment of Medicine, Division of Anaesthesia, University of Cambridge, Cambridge, UK *Corresponding author. Address: FMRIB Centre, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, UK. Tel.: +44 0 1865 222724; fax: +44 0 1865 222717. E-mail address:[email protected] Article history: Received 27 September 2011; Received in revised form 15 September 2012; Accepted 29 September 2012. Pain: January 2013 - Volume 154 - Issue 1 - p 124-134 doi: 10.1016/j.pain.2012.09.017 Buy Metrics Abstract Summary fMRI evidence suggests that delta-9-tetrahydrocannabinol, the psychoactive component of cannabis, targets the affective aspects of pain in humans by altering the activity and functional connections of the amygdala. Cannabis is reported to be remarkably effective for the relief of otherwise intractable pain. However, the bases for pain relief afforded by this psychotropic agent are debatable. Nonetheless, the frontal-limbic distribution of cannabinoid receptors in the brain suggests that cannabis may target preferentially the affective qualities of pain. This central mechanism of action may be relevant to cannabinoid analgesia in humans, but has yet to be demonstrated. Here, we employed functional magnetic resonance imaging to investigate the effects of delta-9-tetrahydrocannabinol (THC), a naturally occurring cannabinoid, on brain activity related to cutaneous ongoing pain and hyperalgesia that were temporarily induced by capsaicin in healthy volunteers. On average, THC reduced the reported unpleasantness, but not the intensity of ongoing pain and hyperalgesia: the specific analgesic effect on hyperalgesia was substantiated by diminished activity in the anterior mid cingulate cortex. In individuals, the drug-induced reduction in the unpleasantness of hyperalgesia was positively correlated with right amygdala activity. THC also reduced functional connectivity between the amygdala and primary sensorimotor areas during the ongoing-pain state. Critically, the reduction in sensory-limbic functional connectivity was positively correlated with the difference in drug effects on the unpleasantness and the intensity of ongoing pain. Peripheral mechanisms alone cannot account for the dissociative effects of THC on the pain that was observed. Instead, the data reveal that amygdala activity contributes to interindividual response to cannabinoid analgesia, and suggest that dissociative effects of THC in the brain are relevant to pain relief in humans. © 2013 Lippincott Williams & Wilkins, Inc.